• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海马体突触处的突触传递波形并非由AMPA受体脱敏所决定。

The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization.

作者信息

Arai A, Lynch G

机构信息

Department of Psychiatry and Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92697, USA.

出版信息

Brain Res. 1998 Jul 20;799(2):230-4. doi: 10.1016/s0006-8993(98)00446-6.

DOI:10.1016/s0006-8993(98)00446-6
PMID:9675293
Abstract

Relationships between the kinetic properties of AMPA receptors and the decay phase of fast excitatory transmission were investigated using modulatory drugs. The benzothiadiazide compound cyclothiazide blocked receptor desensitization in patches excised from hippocampus but had only a weak influence on receptor deactivation, i.e., on the decay of responses produced by a 1-ms pulse of glutamate. The ampakine drug CX516 (BDP-12) produced an opposite pattern of effects: a fourfold slowing of deactivation with little change in desensitization. A structurally related drug (CX554 or BDP-20) had prominent effects on both desensitization and deactivation. The halfwidth of field EPSPs measured in the CA1 region of hippocampal slices increased 50-100% in the presence of CX516 or CX554 but by less than 15% at concentrations of cyclothiazide that fully blocked desensitization in patch experiments. These results indicate that receptor deactivation plays a substantially greater role than receptor desensitization in determining the duration of synaptic responses.

摘要

使用调节药物研究了AMPA受体的动力学特性与快速兴奋性传递衰减阶段之间的关系。苯并噻二嗪化合物环噻嗪可阻断从海马体分离的膜片中受体的脱敏,但对受体失活的影响较弱,即对1毫秒谷氨酸脉冲产生的反应衰减影响较小。安帕金药物CX516(BDP-12)产生了相反的效应模式:失活减慢四倍,脱敏变化不大。一种结构相关药物(CX554或BDP-20)对脱敏和失活均有显著影响。在海马体切片CA1区测量的场兴奋性突触后电位(fEPSP)半宽度在存在CX516或CX554时增加了50%-100%,但在膜片实验中完全阻断脱敏的环噻嗪浓度下增加不到15%。这些结果表明,在确定突触反应持续时间方面,受体失活比受体脱敏起着更大的作用。

相似文献

1
The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization.海马体突触处的突触传递波形并非由AMPA受体脱敏所决定。
Brain Res. 1998 Jul 20;799(2):230-4. doi: 10.1016/s0006-8993(98)00446-6.
2
Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus.α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体动力学的调节对海马体中的突触可塑性有不同影响。
Neuroscience. 2004;123(4):1011-24. doi: 10.1016/j.neuroscience.2003.10.033.
3
Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466.强效安帕金CX614对海马和重组AMPA受体的作用:与环噻嗪和GYKI 52466的相互作用
Mol Pharmacol. 2000 Oct;58(4):802-13. doi: 10.1124/mol.58.4.802.
4
AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices.α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体脱敏调节海马切片中重复传入刺激诱导的突触反应。
Brain Res. 1998 Jul 20;799(2):235-42. doi: 10.1016/s0006-8993(98)00447-8.
5
Lack of AMPA receptor desensitization during basal synaptic transmission in the hippocampal slice.
J Neurophysiol. 1999 Jun;81(6):3096-9. doi: 10.1152/jn.1999.81.6.3096.
6
Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action.苯甲酰胺型AMPA受体调节剂形成两个具有不同作用模式的亚家族。
J Pharmacol Exp Ther. 2002 Dec;303(3):1075-85. doi: 10.1124/jpet.102.040360.
7
Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus.阳性α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体调节剂对丘脑和海马体中的突触传递有不同影响。
J Pharmacol Exp Ther. 2005 Apr;313(1):277-85. doi: 10.1124/jpet.104.078196. Epub 2004 Dec 30.
8
Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.安帕金CX546对变构AMPA受体的调节机制及影响
Neuropharmacology. 2001 Nov;41(6):650-63. doi: 10.1016/s0028-3908(01)00133-2.
9
Effects of cyclothiazide on synaptic responses in slices of adult and neonatal rat hippocampus.环噻嗪对成年和新生大鼠海马体切片中突触反应的影响。
Neuroreport. 1994 Jan 12;5(4):389-92. doi: 10.1097/00001756-199401120-00004.
10
Effects of 5'-alkyl-benzothiadiazides on (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor biophysics and synaptic responses.
Mol Pharmacol. 2002 Sep;62(3):566-77. doi: 10.1124/mol.62.3.566.

引用本文的文献

1
Pharmacological enhancement of memory or cognition in normal subjects.正常受试者记忆或认知的药理学增强。
Front Syst Neurosci. 2014 May 20;8:90. doi: 10.3389/fnsys.2014.00090. eCollection 2014.
2
Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.解析NS9283的作用机制,NS9283是(α4)3(β2)2烟碱型乙酰胆碱受体的正向变构调节剂。
Br J Pharmacol. 2013 Apr;168(8):2000-10. doi: 10.1111/bph.12095.
3
A delayed response enhancement during hippocampal presynaptic plasticity in mice.
小鼠海马体突触前可塑性过程中的延迟反应增强。
J Physiol. 2007 Aug 15;583(Pt 1):129-43. doi: 10.1113/jphysiol.2007.131300. Epub 2007 Jun 14.
4
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.一项针对精神分裂症认知缺陷的安帕金CX516附加安慰剂对照试验。
Neuropsychopharmacology. 2008 Feb;33(3):465-72. doi: 10.1038/sj.npp.1301444. Epub 2007 May 9.
5
Mechanism of positive allosteric modulators acting on AMPA receptors.作用于AMPA受体的正变构调节剂的机制。
J Neurosci. 2005 Sep 28;25(39):9027-36. doi: 10.1523/JNEUROSCI.2567-05.2005.
6
A desensitization-selective potentiator of AMPA-type glutamate receptors.一种AMPA型谷氨酸受体的脱敏选择性增强剂。
Br J Pharmacol. 2002 Aug;136(7):1033-41. doi: 10.1038/sj.bjp.0704804.
7
Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.AMPA/红藻氨酸受体配体的药理学及其在神经和精神疾病中的治疗潜力。
Drugs. 2000 Jan;59(1):33-78. doi: 10.2165/00003495-200059010-00004.
8
Enhancement of AMPA-mediated current after traumatic injury in cortical neurons.创伤性损伤后皮质神经元中AMPA介导电流的增强。
J Neurosci. 1999 Sep 1;19(17):7367-74. doi: 10.1523/JNEUROSCI.19-17-07367.1999.